Urothelial toxicity of esketamine in the treatment of depression

ConclusionsThis study is, to the best of our knowledge, the first to focus on urothelial toxicity of esketamine used in antidepressant indication and dose. The results indicate that the use of single or repeated doses of esketamine is unlikely to cause urothelial toxicity. The results are in need of confirmation as sample size was small.

Source: Psychopharmacology - October 16, 2020 Category: Psychiatry Source Type: research